Let me rewrite this content in a provocative and controversial manner.
The "Obsessed" Entrepreneur: A Deadly Quest for Eternal Life?
Ben Nashman, the 24-year-old founder of Synex Medical, has just secured $21.8 million to develop a portable MRI technology that can allegedly test for glucose and other vital signs without drawing blood. Sounds revolutionary, right? Well, not so fast.
The FDA- approved Detour
It was just a year ago that Nashman was detained by US customs for transporting questionable materials from Buffalo to Toronto. The label on his package? "Nuclear Magnetic Resonance". Sounds like a clever dodgy operation, doesn’t it? And it is.
A Lifelong Obsession with Immortality
Nashman has always been fascinated with eternal life. He convinced his vet to prescribe his sick dog rapamycin, a drug notoriously linked to longevity. The vet thought he was crazy. When he was 16. Yeah, you read that right.
From Experimental Treatments to Unprecedented Risk
Nashman’s obsession with immortality led him to take every questionable treatment he could get his hands on, including a full-body scan by Prenuvo, which costs thousands of dollars, and a continuous glucose monitor. He’s also conducted thousands of self-MRI scans on his own finger. Talk about reckless abandonment of personal safety!
A Crowded Space for Unproven Tech
Synex Medical faces an uphill battle from the off. Not only will the company need to convince the FDA that its machine actually works, but they also need to prove it’s safe and effective. Then, there’s the million-dollar question: can it actually shrink to fit on your palm? Because let’s be real, an MRI the size of a toaster is still an obstacle to overcome.
Industry Skeptics Abound
Khosla Ventures investor Jun Jeon expressed doubts about the viability of Nashman’s project: "There’s not a lot of good infrastructure and reimbursement that will allow for all patients to have access to the technology." What’s more, Synex Medical will need to survive the cutthroat world of healthcare, where innovation comes at a hefty price, and only the most battle-tested companies survive.
So, is Nashman on a quest for immortality or just trying to game the system? Either way, his determination is worth a closer look. As he puts it, "I want to know exactly what my body needs… A technology like this is just needed to usher in that age of predictive medicine."